15 dk gecikmeli
ASELS 348,75 %0,00ASTOR 197,50 %6,81AKBNK 68,15 -%1,59YKBNK 35,66 -%2,57TUPRS 392,25 %3,29THYAO 284,25 -%0,70ISCTR 12,79 -%1,39KCHOL 212,40 %1,34BIMAS 401,00 %1,71TRALT 42,24 %2,18KTLEV 7,28 %9,97SASA 1,88 %1,62SAHOL 88,75 %1,31KLRHO 13,66 -%8,81GARAN 128,50 -%1,08GENIL 4,25 %9,82CITAS 124,20 -%2,28EREGL 36,60 %0,22EKGYO 19,61 %0,05KRDMD 43,02 %0,23TCELL 100,20 %0,80PETKM 20,64 %2,69MIATK 28,72 -%1,24VAKBN 33,66 -%0,06
RVTY logo

RVTY hisse senedi

Revvity Inc.

ABDSağlık ve İlaç

150,63USD

-2,97 (-%1,93)

8 Ekim 2026 22:00 · gecikmeli

Gün Aralığı
149,25 – 156,01
Hacim (adet)
85.774
Piyasa Değeri
13,87 milyar USD
F/K
59,58

RVTY Aylık Getiriler

Ay sonu kapanışlarına göre, USD

YılOcaŞubMarNisMayHazTemAğuEylEkiKasAraToplam
202612,5-9,6-10,9-1,120,76,41,114,418,80,5——%58,76
202513,0-11,1-5,7-11,7-3,27,0-9,12,5-2,76,811,6-7,3-%13,31
2024-1,92,2-4,2-2,46,6-4,019,8-2,44,3-7,2-2,1-3,9%2,10
2023-1,9-9,47,0-2,1-11,63,03,5-4,8-5,4-25,27,323,0-%22,04
2022-14,44,3-2,9-16,02,1-5,07,7-11,8-10,911,04,60,4-%30,26
2021——————————3,010,4%13,66
En İyi AyAra 2023 · %22,96
En Kötü AyEki 2023 · -%25,16
Ortalama Aylık%0,22
Pozitif Ay29 / 60

Günlük Fiyat Verileri

USD · en yeni en üstte

TarihAçılışEn YüksekEn DüşükKapanışDeğişimHacim
21.11.202389,8190,8488,7888,92%0,91519.600
20.11.202387,9788,1386,7988,12%0,17663.000
17.11.202389,0889,0887,7087,97-%0,26631.000
16.11.202389,0989,8087,8188,20-%1,07427.900
15.11.202388,4990,7387,9989,15%1,48790.400
14.11.202386,1588,4286,1587,85%4,56801.400
13.11.202383,9484,6282,7584,02-%0,561,57 milyon
10.11.202383,6984,6082,1784,49%0,39862.800
09.11.202385,2485,4483,9084,16-%1,231,26 milyon
08.11.202385,7586,4083,6485,21-%0,20845.600
07.11.202385,2287,9084,9085,38-%0,19949.500
06.11.202387,8587,9285,2385,54-%2,971,09 milyon
03.11.202386,2888,8485,4988,16%5,011,03 milyon
02.11.202383,6184,4882,9383,95%1,711,16 milyon
01.11.202383,7083,7081,1882,54-%0,371,67 milyon
31.10.202382,4885,0080,9782,85%0,942,14 milyon
30.10.202381,0184,8379,5082,08-%16,134,23 milyon
27.10.202399,41100,0097,2797,87-%1,091,93 milyon
26.10.202399,42101,0098,5098,95-%0,74972.000
25.10.2023100,19100,3296,7099,69-%2,15747.800
24.10.2023101,21102,81100,75101,88-%0,39678.800
23.10.2023100,99104,10100,65102,28%0,60786.000
20.10.2023101,73102,30101,22101,67%0,24774.200
19.10.2023101,61103,00100,99101,43-%0,15662.000
18.10.2023104,50104,50101,49101,58-%3,84604.800
17.10.2023104,63106,48103,69105,64-%0,86462.300
16.10.2023106,67107,62104,87106,56%0,67540.800
13.10.2023105,16106,32104,42105,85%0,28556.900
12.10.2023108,47108,92104,09105,55-%3,15747.300
11.10.2023110,24110,39108,59108,98-%0,99356.300
10.10.2023108,40110,47107,63110,07%1,82595.200
09.10.2023106,78108,38106,14108,10%0,52520.500
06.10.2023105,75108,12105,22107,54%0,88558.100
05.10.2023107,00107,31104,74106,60-%0,78572.000
04.10.2023107,68108,26105,68107,44%0,20768.800
03.10.2023107,21108,03107,01107,23-%0,54486.400
02.10.2023109,88109,88106,75107,81-%2,61635.100
29.09.2023110,72111,73110,20110,70%0,41561.900
28.09.2023109,81110,88109,55110,25%1,10561.200
27.09.2023109,35109,94108,26109,05%0,11425.300
26.09.2023110,60110,82108,93108,93-%1,76455.200
25.09.2023109,81111,00109,44110,88%1,26445.100
22.09.2023108,74110,38107,96109,50%0,93747.000
21.09.2023110,25110,28107,80108,49-%1,74604.100
20.09.2023112,19112,19110,38110,41-%0,67469.000
19.09.2023111,14112,29110,55111,15-%0,30447.500
18.09.2023112,82112,89111,37111,49-%1,72803.800
15.09.2023112,26116,58112,24113,44%0,651,10 milyon
14.09.2023113,00113,51111,47112,71%0,71547.700
13.09.2023108,05112,36107,64111,92%2,52912.300
12.09.2023107,27109,59106,49109,17%1,37807.100
11.09.2023107,09108,48105,83107,69%0,811,12 milyon
08.09.2023109,86109,86105,97106,83-%3,081,03 milyon
07.09.2023111,09111,09109,51110,22-%1,09793.500
06.09.2023112,97112,97108,63111,43-%1,621,34 milyon
05.09.2023116,55116,55113,22113,27-%3,12608.000
01.09.2023118,32119,18116,55116,92-%0,09437.600
31.08.2023119,03119,65116,92117,03-%1,61530.800
30.08.2023118,96119,56118,08118,95-%0,03441.600
29.08.2023117,78119,56116,92118,98%1,37384.700

Yabancı HisselerABDSağlık ve İlaçUSD